Topography studies on the membrane interaction mechanism of the eosinophil cationic protein

Biochemistry

Volumn 46, Issue 3, 2007, Pages 720-733

  Torrent, Marc ^a   Cuyás, Elisabet ^a   Carreras, Esther ^a,d   Navarro, Susanna ^a   López, Olga ^b   De La Maza, Alfons ^b   Nogués, M Victòria ^a   Reshetnyak, Yana K ^c   Boix, Ester ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOLOGICAL MEMBRANES; FLUORESCENCE; IMMUNOLOGY; MOLECULAR STRUCTURE; MUTAGENS; POSITIVE IONS; QUENCHING;

LIPID BILAYERS; PROTEIN INSERTION; PROTEIN MEMBRANE INTERACTION PROCESS; TRYPTOPHAN;

PROTEINS;

EOSINOPHIL CATIONIC PROTEIN; MUTANT PROTEIN; PHOSPHOLIPID; TRYPTOPHAN;

ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE; HOST RESISTANCE; LIGHT SCATTERING; LIPID BILAYER; LIPID VESICLE; MEMBRANE STABILIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

EOSINOPHIL CATIONIC PROTEIN; ESCHERICHIA COLI; FREEZE FRACTURING; HUMANS; LIPID BILAYERS; LIPOSOMES; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; SPECTROMETRY, FLUORESCENCE; TRYPTOPHAN;

EID: 33846384399     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061190e     Document Type: Article

References (72)

1. Venge, P., Bystrom, J., Carlson, M., Hakansson, L., Karawacjzyk, M., Peterson, C., Seveus, L., and Trulson, A. (1999) Eosinophil cationic protein (ECP): Molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease, Clin. Exp. Allergy 29, 1172-1186.
2. Boix, E. (2001) Eosinophil cationic protein, Methods Enzymol. 341, 287-305.
3. Harder, J., and Schroder, J. M. (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 277, 46779-46784.
4. Hooper, L. V., Stappenbeck, T. S., Hong, C. V., and Gordon, J. I. (2003) Angiogenins: A new class of microbicidal proteins involved in innate immunity, Nat. Immunol. 4, 269-273.
5. Cho, S., Beintema, J. J., and Zhang, J. (2005) The ribonuclease A superfamily of mammals and birds: Identifying new members and tracing evolutionary histories, Genomics 85, 208-220.
6. Rosenberg, H. F., and Dyer, K. D. (1995) Eosinophil cationic protein and eosinophil-derived neurotoxin. Evolution of novel function in a primate ribonuclease gene family, J. Biol. Chem. 270, 21539-21544.
7. Rosenberg, H. F., Dyer, K. D., Tiffany, H. L., and Gonzalez, M. (1995) Rapid evolution of a unique family of primate ribonuclease genes, Nat. Genet. 10, 219-223.
8. Bielawski, J. P., and Yang, Z. (2004) A maximum likelihood method for detecting functional divergence at individual codon sites, with application to gene family evolution, J. Mol. Evol. 59, 121-132.
9. Boix, E., Nikolovski, Z., Moiseyev, G. P., Rosenberg, H. F., Cuchillo, C. M., and Nogues, M. V. (1999) Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity, J. Biol. Chem. 274, 15605-15614.
10. Rosenberg, H. F. (1995) Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity, J. Biol. Chem. 270, 7876-7881.
11. Mancheno, J. M., Gasset, M., Onaderra, M., Gavilanes, J. G., and D'Alessio, G. (1994) Bovine seminal ribonuclease destabilizes negatively charged membranes, Biochem. Biophys. Res. Commun. 199, 119-124.
12. Muller, C. A., Autenrieth, I. B., and Peschel, A. (2005) Innate defenses of the intestinal epithelial barrier, Cell. Mol. Life Sci. 62, 1297-1307.
13. Levy, O. (2000) Antimicrobial proteins and peptides of blood: Templates for novel antimicrobial agents, Blood 96, 2664-2672.
14. Gleich, G. J. (2000) Mechanisms of eosinophil-associated inflammation, J. Allergy Clin. Immunol. 105, 651-663.
15. Davis, M. D., Plager, D. A., George, T. J., Weiss, E. A., Gleich, G. J., and Leiferman, K. M. (2003) Interactions of eosinophil granule proteins with skin: Limits of detection, persistence, and vasopermeabilization, J. Allergy Clin. Immunol. 112, 988-994.
16. Hohlfeld, J. M., Schmiedl, A., Erpenbeck, V. J., Venge, P., and Krug, N. (2004) Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma, J. Allergy Clin, Immunol. 113, 496-502.
17. Tai, P. C., Spry, C. J., Peterson, C., Venge, P., and Olsson, I. (1984) Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein, Nature 309, 182-184.
18. Abu-Ghazaleh, R. I., Gleich, G. J., and Prendergast, F. G. (1992) Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: A mechanism for toxicity, J. Membr. Biol. 128, 153-164.
19. Lehrer, R. I., Szklarek, D., Barton, A., Ganz, T., Hamann, K. J., and Gleich, G. J. (1989) Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein, J. Immunol. 142, 4428-4434.
20. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms, Nature 415, 389-395.
21. Lohner, K., and Blondelle, S. E. (2005) Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics, Comb. Chem. High Throughput Screening 8, 241-256.
22. Dathe, M., Meyer, J., Beyermann, M., Maul, B., Hoischen, C., and Bienert, M. (2002) General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides, Biochim. Biophys. Acta 1558, 171-186.
23. Ericksen, B., Wu, Z., Lu, W., and Lehrer, R. I. (2005) Antibacterial activity and specificity of the six human α-defensins, Antimicrob. Agents Chemother. 49, 269-275.
24. Ambroggio, E. E., Separovic, F., Bowie, J. H., Fidelio, G. D., and Bagatolli, L. A. (2005) Direct visualization of membrane leakage induced by the antibiotic peptides: Maculatin, citropin, and aurein, Biophys. J. 89, 1874-1881.
25. Papo, N., and Shai, Y. (2005) Host defense peptides as new weapons in cancer treatment, Cell. MoL. Life Sci. 62, 784-790.
26. Carreras, E., Boix, E., Rosenberg, H. F., Cuchillo, C. M., and Nogues, M. V. (2003) Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein, Biochemistry 42, 6636-6644.
27. Carreras, E., Boix, E., Navarro, S., Rosenberg, H. F., Cuchillo, C. M., and Nogues, M. V. (2005) Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation, Mol. Cell. Biochem. 272, 1-7.
28. Motojima, S., Frigas, E., Loegering, D. A., and Gleich, G. J. (1989) Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro, Am. Rev. Respir. Dis. 139, 801-805.
29. Fredens, K., Dybdahl, H., Dahl, R., and Baandrup, U. (1988) Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage, Acta Pathol. Microbiol. Immunol. Scand. 96, 711-719.
30. Humbles, A. A., Lloyd, C. M., McMillan, S. J., Friend, D. S., Xanthou, G., McKenna, E. E., Ghiran, S., Gerard, N. P., Yu, C., Orkin, S. H., and Gerard, C. (2004) A critical role for eosinophils in allergic airways remodeling, Science 305, 1776-1779.
31. Reshetnyak, Y. K., Koshevnik, Y., and Burstein, E. A. (2001) Decomposition of protein tryptophan fluorescence spectra into lognormal components. III. Correlation between fluorescence and microenvironment parameters of individual tryptophan residues, Biophys. J. 81, 1735-1758.
32. Burstein, E. A., and Emelyanenko, V. I. (1996) Log-normal description of fluorescence spectra of organic fluorophores, Photochem. Photobiol. 64, 316-320.
33. Burstein, E. A., Abornev, S. M., and Reshetnyak, Y. K. (2001) Decomposition of protein tryptophan fluorescence spectra into log-normal components. I. Decomposition algorithms, Biophys. J. 81, 1699-1709.
34. Boix, E., Leonidas, D. D., Nikolovski, Z., Nogues, M. V., Cuchillo, C. M., and Acharya, K. R. (1999) Crystal structure of eosinophil cationic protein at 2.4 Å resolution, Biochemistry 38, 16794-16801.
35. Mallorqui-Fernandez, G., Pous, J., Peracaula, R., Aymami, J., Maeda, T., Tada, H., Yamada, H., Seno, M., de Llorens, R., Gomis-Ruth, F. X., and Coll, M. (2000) Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 Å resolution, J. Mol. Biol. 300, 1297-1307.
36. Mohan, C. G., Boix, E., Evans, H. R., Nikolovski, Z., Nogues, M. V., Cuchillo, C. M., and Acharya, K. R. (2002) The crystal structure of eosinophil cationic protein in complex with 2′,5′-ADP at 2.0 Å resolution reveals the details of the ribonucleolytic active site, Biochemistry 41, 12100-12106.
37. Kitamura, A., Kiyota, T., Tomohiro, M., Umeda, A., Lee, S., Inoue, T., and Sugihara, G. (1999) Morphological behavior of acidic and neutral liposomes induced by basic amphiphilic α-helical peptides with systematically varied hydrophobic-hydrophilic balance, Biophys. J. 76, 1457-1468.
38. Reshetnyak, Y. K., and Burstein, E. A. (2001) Decomposition of protein tryptophan fluorescence spectra into log-normal components. II. The statistical proof of discreteness of tryptophan classes in proteins, Biophys. J. 81, 1710-1734.
39. Ladokhin, A. S. (1999) Analysis of protein and peptide penetration into membranes by depth-dependent fluorescence quenching: Theoretical considerations, Biophys. J. 76, 946-955.
40. McIntosh, T. J., and Holloway, P. W. (1987) Determination of the depth of bromine atoms in bilayers formed from bromolipid probes, Biochemistry 26, 1783-1788.
41. Bartlett, G. R. (1959) Colorimetric assay methods for free and phosphorylated glyceric acids, J. Biol. Chem. 234, 469-471.
42. Johnsen, R. M. (1992) Light Scattering in Biochemistry, The Royal Society of Chemistry, Cambridge, U.K.
43. López, O., López-Iglesias, C., Cócera, M., Walther, P., Parra, J. L., and de la Maza, A. (2004) Influence of chemical and freezing fixation methods in the freeze-fracture of stratum corneum, J. Struct. Biol. 146, 302-309.
44. Egelhaaf, S. U., Wehrli, E., Müller, M., Adrian, M., and Schurtenberger, P. (1996) Determination of the size distribution of lecithin liposomes: A comparative study using freeze fracture, cryoelectron microscopy and dynamic light scattering, J. Microsc. 184, 214-228.
45. Krissinel, E., and Henrick, K. (2005) Detection of Protein Assemblies in Crystals, Vol. LNBI 3695, Springer-Verlag, Berlin, Germany.
46. Sanjeev, B. S., and Vishveshwara, S. (2004) Conformational transitions in eosinophil cationic protein: A molecular dynamics study in aqueous environment, J. Biomol. Struct. Dyn. 22, 171-182.
47. Lehrer, S. S. (1971) Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion, Biochemistry 10, 3254-3263.
48. Lakowicz, J. R. (1983) Principles of Fluorescence Spectroscopy, Plenum Press, New York.
49. 5 in lipid vesicles by fluorescence quenching, Biochemistry 24, 2895-2901.
50. Thoren, P. E., Persson, D., Esbjorner, E. K., Goksor, M., Lincoln, P., and Norden, B. (2004) Membrane binding and translocation of cell-penetrating peptides, Biochemistry 43, 3471-3489.
51. Zhang, J., Rosenberg, H. F., and Nei, M. (1998) Positive Darwinian selection after gene duplication in primate ribonuclease genes, Proc. Natl. Acad. Sci. U.S.A, 95, 3708-3713.
52. Hilpert, K., Volkmer-Engert, R., Walter, T., and Hancock, R. E. (2005) High-throughput generation of small antibacterial peptides with improved activity, Nat. Biotechnol. 23, 1008-1012.
53. Sitaram, N., and Nagaraj, R. (1999) Interaction of antimicrobial peptides with biological and model membranes: Structural and charge requirements for activity, Biochim. Biophys. Acta 1462, 29-54.
54. Oren, Z., and Shai, Y. (1997) Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: Structure-function study, Biochemistry 36, 1826-1835.
55. Brown, K. L., and Hancock, R. E. (2006) Cationic host defense (antimicrobial) peptides, Curr. Opin. Immunol. 18, 24-30.
56. Hancock, R. E., and Chapple, D. S. (1999) Peptide antibiotics, Antimicrob. Agents Chemother. 43, 1317-1323.
57. Papo, N., and Shai, Y. (2003) Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes? Peptides 24, 1693-1703.
58. Reynaud, J. A., Grivet, J. P., Sy, D., and Trudelle, Y. (1993) Interactions of basic amphiphilic peptides with dimyristoylphosphatidylcholine small unilamellar vesicles: Optical, NMR, and electron microscopy studies and conformational calculations, Biochemistry 32, 4997-5008.
59. Yoshimura, T., Goto, Y., and Aimoto, S. (1992) Fusion of phospholipid vesicles induced by an amphiphilic model peptide: Close correlation between fusogenicity and hydrophobicity of the peptide in an α-helix, Biochemistry 31, 6119-6126.
60. Kaznessis, Y. N., Kim, S., and Larson, R. G. (2002) Specific mode of interaction between components of model pulmonary surfactants using computer simulations, J. Mol. Biol. 322, 569-582.
61. Thoren, P. E., Persson, D., Lincoln, P., and Norden, B. (2005) Membrane destabilizing properties of cell-penetrating peptides, Biophys. Chem. 114, 169-179.
62. Ishihara, K., Asai, K., Nakajima, M., Mue, S., and Ohuchi, K. (2003) Preparation of recombinant rat eosinophil-associated ribonuclease-1 and -2 and analysis of their biological activities, Biochim. Biophys. Acta 1638, 164-172.
63. White, G. F., Racher, K. I., Lipski, A., Hallett, F. R., and Wood, J. M. (2000) Physical properties of liposomes and proteoliposomes prepared from Escherichia coli polar lipids, Biochim. Biophys. Acta 1468, 175-186.
64. Wimley, W. C., and White, S. H. (2000) Determining the membrane topology of peptides by fluorescence quenching, Biochemistry 39, 161-170.
65. Yau, W. M., Wimley, W. C., Gawrisch, K., and White, S. H. (1998) The preference of tryptophan for membrane interfaces, Biochemistry 37, 14713-14718.
66. Ridder, A. N., Morein, S., Stam, J. G., Kuhn, A., de Kruijff, B., and Killian, J. A. (2000) Analysis of the role of interfacial tryptophan residues in controlling the topology of membrane proteins, Biochemistry 39, 6521-6528.
67. Young, J. D., Peterson, C. G., Venge, P., and Cohn, Z. A. (1986) Mechanism of membrane damage mediated by human eosinophil cationic protein, Nature 321, 613-616.
68. Liu, L. P., and Deber, C. M. (1997) Anionic phospnolipids modulate peptide insertion into membranes, Biochemistry 36, 5476-5482.
69. Powers, J. P., Tan, A., Ramamoorthy, A., and Hancock, R. E. (2005) Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes, Biochemistry 44, 15504-15513.
70. Shai, Y. (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides, Biochim. Biophys. Acta 1462, 55-70.
71. Gabay, J. E. (1994) Ubiquitous natural antibiotics, Science 264, 373-374.
72. D'Costa, V. M., McGrann, K. M., Hughes, D. W., and Wright, G. D. (2006) Sampling the antibiotic resistome, Science 311, 374-377.